SCHEMBL7989564

SCHEMBL7989564

CCCCCc1nc2ncn(Cc3ccccc3)c2c(=O)[nH]1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.54
ALDH1A1 P00352 2/20 0.54
HPGD P15428 1/20 0.54
KMT2A Q03164 1/20 0.53
HCAR2 Q8TDS4 4/20 0.47
BRD4 O60885 1/20 0.46
PARP1 P09874 1/20 0.46
ADORA2B P29275 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
POLB P06746 2/20 0.42
HIF1A Q16665 1/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
MAPK1 P28482 1/20 0.42
PARN O95453 1/20 0.42
CNOT7 Q9UIV1 1/20 0.42
PNP P00491 1/20 0.42
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987608 0.97 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HPGDKMT2AHCAR2
SCHEMBL7989405 0.92 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1HPGDKMT2AHCAR2
SCHEMBL7985314 0.87 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HPGDKMT2AHCAR2
SCHEMBL7975251 0.87 SMN1; SMN2 (0.60) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL7988836 0.87 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1HPGDKMT2AHCAR2
Hydrochloric Acid SCHEMBL7987741 0.86 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1HPGDKMT2AHCAR2
Hydrochloric Acid SCHEMBL7975095 0.86 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1HPGDKMT2AHCAR2
SCHEMBL7985634 0.85 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1HPGDKMT2AHCAR2
SCHEMBL7987702 0.84 SMN1; SMN2 (0.60) SMN1; SMN2ALDH1A1HPGDKMT2AHCAR2
Hydrochloric Acid SCHEMBL7987615 0.84 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1HPGDKMT2AHCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed